Company: OrbiMed Advisors
Job title: Venture Partner
Panel Discussion: Navigating the Catch-22 With GBM Funding: How Can Investors & Companies Work Together to Solve This Dilemma?
Moderated by: Scott Rakestraw 9:30 am
Addressing how to attract investment for the indication that the proposition has not yet been clinically proven Discussing gaining support for novel strategies, including combination trials especially when monotherapy has not been proven in isolation Evaluating preclinical models in their reliability to reflect clinical outcomes and which models appeal to investors the most Comparing the…Read more
day: Conference Day Two